Article Text

Download PDFPDF

Correspondence
Another aspect-oriented approach to diagnosis of cardiac amyloidosis
Free
  1. Narat Srivali,
  2. Supawat Ratanapo,
  3. Patompong Ungprasert,
  4. Wisit Cheungpasitporn
  1. Department of Medicine, Bassett Medical Center, Cooperstown, New York, USA
  1. Correspondence to Dr Wisit Cheungpasitporn, Department of Medicine, Bassett Medical Center, Cooperstown, NY 13326, USA; wisit.c{at}hotmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with interest the article by Esterbrook et al 1 on cardiac amyloidosis. Authors demonstrated very excellent clinical presentation and a challenging diagnostic work-up in a patient with cardiac amyloidosis presenting with cough and breathlessness. However, we would like to discuss on another possible straightforward diagnostic approach for this case.

A combination of poor R progression on ECG without evidence of coronary artery disease and echocardiographic features of increased ventricular wall thickness in normotensive patients should raise the suspicion of infiltrative heart diseases especially amyloidosis.2 Urine studies including urine protein to creatinine ratio and urine protein electrophoresis are essential from the fact that proteinuria is present in more than 90% of the cases of amyloidosis.3 Serum and urine immunofixation can reveal an abnormal monoclonal band in approximately 90% of the cases with primary (AL) amyloidosis as in the case presentation. However, monoclonal protein is present in lower concentration in AL amyloidosis compared with multiple myeloma. So, serum-free light chain assay is a very helpful quantitative test that is abnormal in more than 95% of the cases and should be included in the diagnostic work-up for amyloidosis.4 An excess of lambda or (less common) kappa from serum-free light chain assay can promptly guide us to the diagnosis of AL amyloidosis.

References

View Abstract

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; internally peer reviewed.